The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.

Pubmed ID: 24173404

Journal: International journal of obesity (2005)

Publication Date: Aug. 1, 2014

Affiliation: Department of Medicine, Hospital Universitari Germans Trias i Pujol UAB, Barcelona, Spain.

MeSH Terms: Humans, Male, Adult, Female, Risk Factors, Survival Analysis, Body Mass Index, Proportional Hazards Models, Heart Failure, Prognosis, Comorbidity, Stroke Volume, Obesity

Authors: Ahmed A, Ahmed A, McAlister FA, McAlister FA, Gamble GD, Gamble GD, Thompson SG, Rich MW, Rich MW, Brett M, Wood DA, Doughty RN, Doughty RN, Doughty RN, McMurray JJ, McMurray JJ, Poppe KK, Whalley GA, Ezekowitz J, Ezekowitz J, Squire IB, Coats AJ, Andersson B, Andersson B, Pfeffer MA, Martínez-Sellés M, Martínez-Sellés M, Poppe K, Poppe K, Poppe K, Poppe K, Earle N, Earle N, Tribouilloy C, Tribouilloy C, Swedberg K, Swedberg K, Swedberg K, Swedberg K, Køber L, Køber L, Køber L, Berry C, Berry C, Berry C, Squire I, Whalley G, Whalley G, Whalley G, Whalley G, Whalley G, Hall C, Richards AM, Troughton R, Troughton R, Lainchbury J, Hogg K, Norrie J, Stevenson K, McMurray J, McMurray J, Granger CB, Michelson EL, Olofsson B, Yusuf S, Torp-Pedersen C, Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, Cleland J, Komajda M, Komajda M, Gotsman I, Gotsman I, Zwas D, Planer D, Azaz-Livshits T, Admon D, Lotan C, Keren A, Grigorian-Shamagian L, Grigorian-Shamagian L, Varela-Roman A, Varela-Roman A, Rigeiro-Veloso P, Bandin-Dieguez MA, Gonzalez-Juanatey JR, Gonzalez-Juanatey JR, Gonzalez-Juanatey JR, Guazzi M, Guazzi M, Myers J, Arena R, Armstrong PW, Cujec B, Paterson I, Cowie MR, Cowie MR, Suresh V, Poole-Wilson PA, Sutton GC, Robles JA, Prieto L, Muñoa MD, Frades E, Díaz-Castro O, Almendral J, Almendral J, Tarantini L, Tarantini L, Faggiano P, Senni M, Senni M, Lucci D, Lucci D, Bertoli D, Porcu M, Opasich C, Tavazzi L, Maggioni AP, Kirk V, Bay M, Parner J, Krogsgaard K, Herzog TM, Boesgaard S, Hassager C, Nielsen OW, Aldershvile J, Macín SM, Perna ER, Alvarenga P, Pantich R, Ríos N, Farias EF, Badaracco JR, Madsen BK, Hansen JF, Stokholm KH, Brons J, Husum D, Mortensen LS, Bayes-Genis A, Bayes-Genis A, Bayes-Genis A, Vazquez R, Puig T, Fernandez-Palomeque C, Bardajı A, Pascual-Figal D, Ordoñez-Llanos J, Valdes M, Gabarrus A, Pavon R, Pastor L, Fiol M, Nieto V, Macaya C, Cinca J, Newton JD, Blackledge HM, Wright SP, Kerzner R, Gage BF, Freedland KE, Freedland KE, Huynh BC, Rovner A, Carney RM, Taffet GE, Teasdale TA, Bleyer AJ, Kutka NJ, Luchi RJ, Rusinaru D, Mahjoub H, Soulière V, Lévy F, Peltier M, Tsutsui H, Tsutsui H, Tsuchihashi M, Takeshita A, MacCarthy PA, Kearney MT, Cubbon R, Nolan J, Lee AJ, Prescott RJ, Shah AM, Brooksby WP, Fox KA, Basante P, Trillo R, Garcia-Seara J, Martinez-Sande JL, Gude F, Pocock S, Pocock S, Pocock S, Doughty R, Doughty R, Doughty R, Granger C, Massie B, McAlister F, McAlister F, Somaratne J, Cowie M, Gonzalez-Juanatey J, Gorini M, Kearney M, di Lenarda A, Lenzen M, Madsen B, Maggioni A, Maggioni A, Oliva F, Rich M, Rich M, Richards M, Taffet G, Ariti C, Ariti C, Dobson J, Held P, Canella JP, Östergren J, Padwal R, Gamble G, Macı S, Maózn-Ramos P, Kober HN, de Luna AB, Heart UK

Cite As: Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A, Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 2014 Aug;38(8):1110-4. Epub 2013 Oct 31.

Studies:

Abstract

BACKGROUND: In heart failure (HF), obesity, defined as body mass index (BMI) ≥30 kg m(-2), is paradoxically associated with higher survival rates compared with normal-weight patients (the 'obesity paradox'). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fraction (HF-REF) versus preserved ejection fraction (HF-PEF)). PATIENTS AND METHODS: A sub-analysis of the MAGGIC meta-analysis of patient-level data from 14 HF studies was performed. Subjects were divided into five BMI groups: <22.5, 22.5-24.9 (referent), 25-29.9, 30-34.9 and ≥35 kg m(-2). Cox proportional hazards models adjusted for age, sex, aetiology (ischaemic or non-ischaemic), hypertension, diabetes and baseline blood pressure, stratified by study, were used to examine the independent association between BMI and 3-year total mortality. Analyses were conducted for the overall group and within HF-REF and HF-PEF groups. RESULTS: BMI data were available for 23 967 subjects (mean age, 66.8 years; 32% women; 46% NYHA Class II; 50% Class III) and 5609 (23%) died by 3 years. Obese patients were younger, more likely to receive cardiovascular (CV) drug treatment, and had higher comorbidity burdens. Compared with BMI levels between 22.5 and 24.9 kg m(-2), the adjusted relative hazards for 3-year mortality in subjects with HF-REF were: hazard ratios (HR)=1.31 (95% confidence interval=1.15-1.50) for BMI <22.5, 0.85 (0.76-0.96) for BMI 25.0-29.9, 0.64 (0.55-0.74) for BMI 30.0-34.9 and 0.95 (0.78-1.15) for BMI ≥35. Corresponding adjusted HRs for those with HF-PEF were: 1.12 (95% confidence interval=0.80-1.57) for BMI <22.5, 0.74 (0.56-0.97) for BMI 25.0-29.9, 0.64 (0.46-0.88) for BMI 30.0-34.9 and 0.71 (0.49-1.05) for BMI ≥35. CONCLUSIONS: In patients with chronic HF, the obesity paradox was present in both those with reduced and preserved ventricular systolic function. Mortality in both HF subtypes was U-shaped, with a nadir at 30.0-34.9 kg m(-2).